Sat, Aug 13, 2022
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UBS O'Connor expands with healthcare-focused investment team

Wednesday, February 23, 2022
Opalesque Industry Update - UBS O'Connor, the multi-strategy hedge fund manager within UBS Asset Management, announced today that it has hired Jason Bonadio MD, Robert Sweeney MD, and Adam Sandler MD to manage a relative value equity strategy focusing on the healthcare therapeutics industry.

"Our new investment team at O'Connor brings a combination of biomedical expertise and investment experience that enables us to identify healthcare companies trading well below their intrinsic value. This segment of the market, which has always been prone to high dispersion of returns and high barriers to investment participation, due to the scientific and data complexity of the industry, creates an investment opportunity set ideal for alpha generation and uncorrelated returns," said Kevin Russell, Chief Investment Officer of O'Connor.

Dr. Jason Bonadio joins as a Healthcare Portfolio Manager. Prior to this role, he co-founded Alera Partners, a long/short equity healthcare fund investing in the biotechnology, medical technology, pharmaceutical and life science tools sectors. Dr. Bonadio was also a founding partner and a co-portfolio manager of the FrontPoint Healthcare Funds.

Dr. Robert Sweeney joins as a Healthcare Research Analyst. Dr. Sweeney is a board-eligible surgeon that joined Alera Partners in 2021. Previously, he worked as a sell-side equity research analyst at H.C. Wainwright, with coverage across therapeutic areas and medical devices. He is currently a Ph.D. candidate in Immunology at the Icahn School of Medicine at Mount Sinai in NYC.

Dr. Adam Sandler joins as a Healthcare Research Analyst. Dr. Sandler is currently the chief resident in the Department of Occupational Medicine at Mount Sinai. He joined Alera Partners in 2021 and was previously a healthcare analyst at Guidepoint Global. After graduating, cum laude from Harvard University in 2004, he received awards for his work from the New York Academy of Medicine, Crohn's and Colitis Foundation of America, and Adenosine Therapeutics at Mount Sinai School of Medicine.

O'Connor has USD 11.2 billion in assets under management as of February 1, 2022. UBS Asset Management is a large scale asset manager with over USD 1.2 trillion in invested assets across its traditional asset management, hedge fund, real estate, infrastructure and private equity businesses.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: ESG exuberance is at all-time highs. But will investors buy?[more]

    As investors increase their focus on mission-based investing, they continue to grapple with ESG and what it means to them. By David Shalom, Director of Capital Introductions at Pershing Innovation. New investment solutions. That's how managers deliver value and attract new inve

  2. Alts managers sitting on over $2.5tn+ of dry powder[more]

    Laxman Pai, Opalesque Asia: In the current rising interest rate environment, investment activity in the private markets has continued to grow, revealed a study. "With alts managers sitting on over $2.5T+ of dry powder and continuing to enjoy premium valuations and interest rates on a prec

  3. Opalesque Exclusive: Hong Kong manager expects additional tailwind in Asian markets[more]

    B. G., Opalesque Geneva: The Asia equity markets have not been at their best so far this year, with the MSCI Asia index down almost 13% YTD, but many managers remain buoyant about the region, as in

  4. Opalesque Exclusive: Emerging markets persist despite headwinds[more]

    Bailey McCann, Opalesque New York: Emerging markets have been under significant pressure since the start of the year, but there are some nascent trends that suggest that things could be getting better. Emerging markets firm Gramercy Fund Management recently released its third quarter outlook and

  5. Opalesque Exclusive: Castle Hall's DiligenceExchange free Transparency Reports cover 100 managers with $10tn of assets[more]

    Matthias Knab, Opalesque for New Managers: Managers and investors can get free access to DiligenceExchange here: Castle Hall, the Du